These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 19536779

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Characterisation of the role of zinc in the hepatitis C virus NS2/3 auto-cleavage and NS3 protease activities.
    Tedbury PR, Harris M.
    J Mol Biol; 2007 Mar 09; 366(5):1652-60. PubMed ID: 17239391
    [Abstract] [Full Text] [Related]

  • 3. The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic.
    Tsantrizos YS.
    Biopolymers; 2004 Mar 09; 76(4):309-23. PubMed ID: 15386268
    [Abstract] [Full Text] [Related]

  • 4. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
    De Francesco R, Pessi A, Steinkühler C.
    Antivir Ther; 1998 Mar 09; 3(Suppl 3):99-109. PubMed ID: 10726060
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex.
    McCoy MA, Senior MM, Gesell JJ, Ramanathan L, Wyss DF.
    J Mol Biol; 2001 Feb 02; 305(5):1099-110. PubMed ID: 11162117
    [Abstract] [Full Text] [Related]

  • 7. Conformational stability of hepatitis C virus NS3 protease.
    Abian O, Vega S, Neira JL, Velazquez-Campoy A.
    Biophys J; 2010 Dec 01; 99(11):3811-20. PubMed ID: 21112306
    [Abstract] [Full Text] [Related]

  • 8. NS3 protease from hepatitis C virus: biophysical studies on an intrinsically disordered protein domain.
    Vega S, Neira JL, Marcuello C, Lostao A, Abian O, Velazquez-Campoy A.
    Int J Mol Sci; 2013 Jun 26; 14(7):13282-306. PubMed ID: 23803659
    [Abstract] [Full Text] [Related]

  • 9. Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
    Zhou H, Singh NJ, Kim KS.
    Proteins; 2006 Nov 15; 65(3):692-701. PubMed ID: 16972281
    [Abstract] [Full Text] [Related]

  • 10. The RNA aptamer-binding site of hepatitis C virus NS3 protease.
    Hwang J, Fauzi H, Fukuda K, Sekiya S, Kakiuchi N, Shimotohno K, Taira K, Kusakabe I, Nishikawa S.
    Biochem Biophys Res Commun; 2000 Dec 20; 279(2):557-62. PubMed ID: 11118325
    [Abstract] [Full Text] [Related]

  • 11. NS3 serine protease of bovine viral diarrhea virus: characterization of active site residues, NS4A cofactor domain, and protease-cofactor interactions.
    Tautz N, Kaiser A, Thiel HJ.
    Virology; 2000 Aug 01; 273(2):351-63. PubMed ID: 10915606
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.
    Liu D, Wang YS, Gesell JJ, Wyss DF.
    J Mol Biol; 2001 Nov 30; 314(3):543-61. PubMed ID: 11846566
    [Abstract] [Full Text] [Related]

  • 14. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.
    Wei HY, Lu CS, Lin TH.
    J Mol Graph Model; 2008 Apr 30; 26(7):1131-44. PubMed ID: 18024210
    [Abstract] [Full Text] [Related]

  • 15. Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein.
    Chen M, Sällberg M, Sönnerborg A, Jin L, Birkett A, Peterson D, Weiland O, Milich DR.
    Hepatology; 1998 Jul 30; 28(1):219-24. PubMed ID: 9657115
    [Abstract] [Full Text] [Related]

  • 16. The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism.
    Barbato G, Cicero DO, Nardi MC, Steinkühler C, Cortese R, De Francesco R, Bazzo R.
    J Mol Biol; 1999 Jun 04; 289(2):371-84. PubMed ID: 10366511
    [Abstract] [Full Text] [Related]

  • 17. An RNA ligand inhibits hepatitis C virus NS3 protease and helicase activities.
    Fukuda K, Umehara T, Sekiya S, Kunio K, Hasegawa T, Nishikawa S.
    Biochem Biophys Res Commun; 2004 Dec 17; 325(3):670-5. PubMed ID: 15541341
    [Abstract] [Full Text] [Related]

  • 18. NMR structural characterization of peptide inhibitors bound to the Hepatitis C virus NS3 protease: design of a new P2 substituent.
    Goudreau N, Cameron DR, Bonneau P, Gorys V, Plouffe C, Poirier M, Lamarre D, Llinas-Brunet M.
    J Med Chem; 2004 Jan 01; 47(1):123-32. PubMed ID: 14695826
    [Abstract] [Full Text] [Related]

  • 19. Investigating the origin of the slow-binding inhibition of HCV NS3 serine protease by a novel substrate based inhibitor.
    Liu Y, Saldivar A, Bess J, Solomon L, Chen CM, Tripathi R, Barrett L, Richardson PL, Molla A, Kohlbrenner W, Kati W.
    Biochemistry; 2003 Jul 29; 42(29):8862-9. PubMed ID: 12873147
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the domain interactions between the protease and helicase of NS3 in dengue and hepatitis C virus.
    Rosales-León L, Ortega-Lule G, Ruiz-Ordaz B.
    J Mol Graph Model; 2007 Jan 29; 25(5):585-94. PubMed ID: 16762573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.